Arthritis advocates urge Congress to take action to address drug costs, access issues

September 26, 2017, American College of Rheumatology

Physician and healthcare professional advocates from the American College of Rheumatology (ACR) are joined by rheumatology patients on Capitol Hill this week to urge lawmakers to address the significant drug cost and access issues affecting millions of Americans living with arthritis and other rheumatologic diseases. More than 100 advocates met with Congressional and Senate leaders and staff today to advocate for meaningful legislative reforms that would lower biologic drug costs and make life-changing therapies and treatments more accessible to the 54 million Americans living with rheumatic diseases.

"All across America, people living with chronic illnesses like rheumatoid arthritis are routinely denied timely, life-sustaining and clinically appropriate treatments because of cost or access issues," said Sharad Lakhanpal, MBBS, MD, President of the American College of Rheumatology. "We are urging Congressional leaders to come together around common-sense reforms that will ensure their constituents can access and afford the therapies and services needed to avoid long-term disability, remain active in the workforce and their communities, and maintain quality of life."

Rheumatology advocates urged Congressional leaders to support legislative fixes that would help address the following issues impacting patient care:

  • Specialty Drug Co-Pays: Health insurers are increasingly making biologic and biosimilar therapies unaffordable for patients by placing them on so called "specialty tiers," which requires that beneficiaries pay a percentage of the drug's cost rather than a fixed co-pay amount. These patients are often faced with the choice of paying hundreds of dollars per month in co-pays for biologic therapies, or reducing or skipping their medications due to cost concerns. ACR advocates are urging Congressional leaders to support the Patients' Access to Treatments Act (H.R. 2999), a bipartisan bill recently introduced by Rep. David McKinley (R-WV) and Rep. G.K. Butterfield (D-NC) that would require health plans to limit patient cost-sharing for drugs placed on specialty tiers.
  • Pharmacy Benefit Manager (PBM) Pricing Practices: As the go-between hired by insurers to manage drug benefit programs, Pharmacy Benefit Managers (PBMs) were originally created to control by negotiating discounts on the behalf of patients. However, PBMs have recently become incredibly effective at keeping much of the savings for themselves by often pocketing the difference between the fees they charge to pharmacies and the prices they negotiate from manufacturers - prices that are almost always kept secret. This secrecy drives up co-pays and out-of-pocket for patients while delivering record profits to PBMs. ACR advocates are urging Congress to consider requiring PBMs to be more transparent about their payment practices and make it harder to hide the true cost of prescription drugs from patients.
  • Medicare Therapy Caps: ACR advocates are also urging members of Congress to support the bipartisan Medicare Access to Rehabilitation Services Act of 2017 (H.R. 807 and S. 253) which would repeal once and for all the Medicare therapy caps scheduled to go into effect in 2018. This arbitrary payment cap would severely limit access to vital rehabilitation services like physical and occupational therapy for Medicare beneficiaries living with chronic diseases. Though Congress has come together to delay implementation of the caps more than 13 times since they were first introduced in 1997, they have yet to be permanently repealed.

"I'm encouraged by the dedication and enthusiasm on display from our members today, as well as the positive reception we received from legislative offices," said Dr. Angus Worthing, Chair of the ACR's Government Affairs Committee. "Many Congressional and Senate leaders recognize that costs are a significant problem; now we need them to come together around practical solutions that will bring relief to our . I'd like to thank all of our advocates for coming out this week and supporting policies that will truly make a positive difference for the millions of Americans living with ."

The advocacy appeals to Senate and Congressional leaders come as arthritis patient and provider advocates throughout the nation recognize September's Rheumatic Disease Awareness Month.

Explore further: ACR announces 2017 health policy priorities

Related Stories

ACR announces 2017 health policy priorities

March 31, 2017
The American College of Rheumatology today announced its 2017 health policy priorities, providing detailed policy recommendations to improve access to care and treatments for the 54 million Americans living with arthritis ...

Patients grapple with high cost of arthritis medications

April 21, 2015
The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...

ACR supports patients' access to treatments act of 2013

February 12, 2013
(HealthDay)—The American College of Rheumatology (ACR) has joined the Coalition for Accessible Treatments, in support of the Patients' Access to Treatments Act of 2013, which will reduce the out-of-pocket expenses for medications, ...

Studies show high out-of pocket costs limit access to lifesaving specialty drugs

March 28, 2016
"Specialty drugs" have become important treatment options for many serious and chronic diseases, and in some conditions like cancer they represent the only chance for long-term survival. But, insurers increasingly require ...

ACP brings prescription to improve American health care to Congress

May 23, 2017
The American College of Physicians today released a set of recommendations aimed at providing a forward-thinking agenda for health care reform, 'A Prescription for a Forward-Looking Agenda to Improve American Health Care.' ...

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Recommended for you

A low-gluten, high-fiber diet may be healthier than gluten-free

November 16, 2018
When healthy people eat a low-gluten and fibre-rich diet compared with a high-gluten diet, they experience less intestinal discomfort including less bloating. Researchers at University of Copenhagen show that this is due ...

Youth dating violence shaped by parents' conflict-handling views, study finds

November 16, 2018
Parents who talk to their children about nonviolent ways of resolving conflict may reduce children's likelihood of physically or psychologically abusing their dating partners later—even when parents give contradictory messages ...

Why we shouldn't like coffee, but we do

November 15, 2018
Why do we like the bitter taste of coffee? Bitterness evolved as a natural warning system to protect the body from harmful substances. By evolutionary logic, we should want to spit it out.

Dietary fat is good? Dietary fat is bad? Coming to consensus

November 15, 2018
Which is better, a low-fat/high-carbohydrate diet or a high-fat/low-carbohydrate diet—or is it the type of fat that matters? In a new paper featured on the cover of Science magazine's special issue on nutrition, researchers ...

Low-carb diets cause people to burn more calories

November 14, 2018
Most people regain the weight they lose from dieting within one or two years, in part because the body adapts by slowing metabolism and burning fewer calories. A meticulous study led by Boston Children's Hospital, in partnership ...

Colder, darker climates increase alcohol consumption and liver disease

November 14, 2018
Where you live could influence how much you drink. According to new research from the University of Pittsburgh Division of Gastroenterology, people living in colder regions with less sunlight drink more alcohol than their ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.